ROCHE MOLECULAR SYSTEMS COBAS TAQSCREEN MPX TEST V2; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GROUP M AND O RNA, HIV-2 RNA, HCV
|
Back to Search Results |
|
Catalog Number 05969484190 |
Device Problem
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 02/16/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
Medical opinion indicated that a (b)(6) nat would not prohibit the use of autologous stem cell products in the us; however, the institution's policy with regards to storage and distribution of such products or what the clinician would do is up to them.Although requested, it is unknown what decision was made for the affected autologous stem cell donor.There may be a potential delay in treatment pending further evaluation of the patient's infection status.However, no harm has been indicated to date.No issues were identified with the complaint kit lot during the investigation.The product common name was truncated and the complete name is "human immunodeficiency virus type 1 (hiv-1) group m rna, hiv-1 group o rna, human immunodeficiency virus type 2 (hiv-2) rna, hepatitis c virus (hcv) rna and hepatitis b virus (hbv) dna assay".(b)(4).
|
|
Event Description
|
A customer alleged a potential (b)(6) result while using the cobas taqscreen mpx test v2.An autologous stem cell donor obtained a (b)(6) with the cobas taqscreen mpx test v2 on (b)(6) 2019.This donor has tested (b)(6) with 3 collections in the previous 6 months ((b)(6) 2018, (b)(6) 2018, (b)(6) 2019), and 1 new collection ((b)(6) 2019).The donor was serology (b)(6).No harm has been indicated to date.
|
|
Search Alerts/Recalls
|
|
|